IFP Advisors, Inc - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 40 filers reported holding CASI PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$020.0%0.00%
Q1 2018$020.0%0.00%
Q4 2017$02
-33.3%
0.00%
Q3 2017$030.0%0.00%
Q2 2017$030.0%0.00%
Q1 2017$030.0%0.00%
Q4 2016$03
+200.0%
0.00%
Q3 2016$01
-96.4%
0.00%
Q2 2016$0280.0%0.00%
Q4 2015$0280.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
IDG-Accel China Growth Fund III Associates L.P. 7,973,536$19,136,00025.80%
Consonance Capital Management LP 10,540,715$25,298,0002.70%
Wellington Shields & Co., LLC 1,832,769$4,399,0001.58%
Tri Locum Partners LP 1,500,000$3,600,0000.89%
Wellington Shields Capital Management, LLC 2,231,765$5,356,0000.51%
Ghost Tree Capital, LLC 650,000$1,560,0000.37%
1492 Capital Management LLC 159,486$382,0000.11%
Ikarian Capital, LLC 1,268,154$3,044,0000.10%
Sio Capital Management, LLC 203,432$488,0000.10%
Aristides Capital LLC 63,250$152,0000.06%
View complete list of CASI PHARMACEUTICALS INC shareholders